Galectin Therapeutics Inc. (GALT)

[thefamilyman]

A change in management might do the trick... We had established a price in the $15 range. Then Traber withheld the information about the change in protocol for Cohort 2. A few months later that deception was revealed, investors sold, and our share price tanked. Most of those investors obviously haven't come back and I think our dishonest CEO is the reason.

The trial results since the Cohort 2 fiasco have been good. If investors believed in the product before, they have even more reason to believe in it now. But the share price says that those investors have not come back. I think that they are waiting for the company to address the obvious integrity problem that exist with the company's management. And yes that problem may be more than just Traber...

If they don't fire someone, they need to get professional help to rebuild the company's reputation with the investment community. I wouldn't be surprised to learn that many institutional investors have GALT on a "No Buy" list.

It's frustrating to watch it fizzle like this. Funny thing is, I still believe that the compound is likely effective (based on results to date). Nothing has changed for me in that regard. I just hope mgmt can pull us out of this nosedive. The only thing readily apparent to me that might do that anytime soon would be some fantastic results from the melanoma combo trials. But then they are such a small sample size that it could be written off by investors. Maybe the psoriasis trial? I don't think word of the NASH trials starting would be likely to move the SP much, not for a while.

I've pretty much accepted the idea that the money I've invested here is going to be here for a while. Trying to exercise patience.
- Darwinian